HPV self-sampling as an alternative strategy in non-attenders for cervical screening – a randomised controlled trial

por Szarewski, A, Cadman, L, Mesher, D, Austin, J, Ashdown-Barr, L, Edwards, R, Lyons, D, Walker, J, Christison, J, Frater, A, Waller, J
Publicado 2011

Molecular detection of persistent postoperative circulating tumour cells in stages II and III colon cancer patients via multiple blood sampling: prognostic significance of detectio...

por Lu, C-Y, Uen, Y-H, Tsai, H-L, Chuang, S-C, Hou, M-F, Wu, D-C, Hank Juo, S-H, Lin, S-R, Wang, J-Y
Publicado 2011

Levels of circulating CD45(dim)CD34(+)VEGFR2(+) progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors

por Farace, F, Gross-Goupil, M, Tournay, E, Taylor, M, Vimond, N, Jacques, N, Billiot, F, Mauguen, A, Hill, C, Escudier, B
Publicado 2011

Long-term clinical outcome of oestrogen receptor-positive operable primary breast cancer in older women: a large series from a single centre

por Syed, B M, Al-Khyatt, W, Johnston, S J, Wong, D W M, Winterbottom, L, Kennedy, H, Green, A R, Morgan, D A L, Ellis, I O, Cheung, K L
Publicado 2011

Mediterranean dietary pattern and cancer risk in the EPIC cohort

por Couto, E, Boffetta, P, Lagiou, P, Ferrari, P, Buckland, G, Overvad, K, Dahm, C C, Tjønneland, A, Olsen, A, Clavel-Chapelon, F, Boutron-Ruault, M-C, Cottet, V, Trichopoulos, D, Naska, A, Benetou, V, Kaaks, R, Rohrmann, S, Boeing, H, von Ruesten, A, Panico, S, Pala, V, Vineis, P, Palli, D, Tumino, R, May, A, Peeters, P H, Bueno-de-Mesquita, H B, Büchner, F L, Lund, E, Skeie, G, Engeset, D, Gonzalez, C A, Navarro, C, Rodríguez, L, Sánchez, M-J, Amiano, P, Barricarte, A, Hallmans, G, Johansson, I, Manjer, J, Wirfärt, E, Allen, N E, Crowe, F, Khaw, K-T, Wareham, N, Moskal, A, Slimani, N, Jenab, M, Romaguera, D, Mouw, T, Norat, T, Riboli, E, Trichopoulou, A
Publicado 2011

Differential trends in the rising incidence of endometrial cancer by type: data from a UK population-based registry from 1994 to 2006

por Evans, T, Sany, O, Pearmain, P, Ganesan, R, Blann, A, Sundar, S
Publicado 2011

An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer

por Lee, H E, Kim, J H, Kim, Y J, Choi, S Y, Kim, S-W, Kang, E, Chung, I Y, Kim, I A, Kim, E J, Choi, Y, Ryu, H S, Park, S Y
Publicado 2011

Hepatitis B virus X protein downregulates expression of the miR-16 family in malignant hepatocytes in vitro

por Wu, G, Yu, F, Xiao, Z, Xu, K, Xu, J, Tang, W, Wang, J, Song, E
Publicado 2011

Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma

por Komatsu, S, Ichikawa, D, Takeshita, H, Tsujiura, M, Morimura, R, Nagata, H, Kosuga, T, Iitaka, D, Konishi, H, Shiozaki, A, Fujiwara, H, Okamoto, K, Otsuji, E
Publicado 2011

NF-κB mediates the 12(S)-HETE-induced endothelial to mesenchymal transition of lymphendothelial cells during the intravasation of breast carcinoma cells

por Vonach, C, Viola, K, Giessrigl, B, Huttary, N, Raab, I, Kalt, R, Krieger, S, Vo, T P N, Madlener, S, Bauer, S, Marian, B, Hämmerle, M, Kretschy, N, Teichmann, M, Hantusch, B, Stary, S, Unger, C, Seelinger, M, Eger, A, Mader, R, Jäger, W, Schmidt, W, Grusch, M, Dolznig, H, Mikulits, W, Krupitza, G
Publicado 2011

Quercetin downregulates Mcl-1 by acting on mRNA stability and protein degradation

por Spagnuolo, C, Cerella, C, Russo, M, Chateauvieux, S, Diederich, M, Russo, G L
Publicado 2011

Radiation-enhancement of MDA-MB-231 breast cancer cell invasion prevented by a cyclooxygenase-2 inhibitor

por Paquette, B, Therriault, H, Desmarais, G, Wagner, R, Royer, R, Bujold, R
Publicado 2011

Phase II trial of modified FOLFOX6 and erlotinib in patients with metastatic or advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction

por Wainberg, Z A, Lin, L-S, DiCarlo, B, Dao, K M, Patel, R, Park, D J, Wang, H-J, Elashoff, R, Ryba, N, Hecht, J R
Publicado 2011

A two-phase case–control study for colorectal cancer genetic susceptibility: candidate genes from chromosomal regions 9q22 and 3q22

por Abulí, A, Fernández-Rozadilla, C, Giráldez, M D, Muñoz, J, Gonzalo, V, Bessa, X, Bujanda, L, Reñé, J M, Lanas, A, García, A M, Saló, J, Argüello, L, Vilella, À, Carreño, R, Jover, R, Xicola, R M, Llor, X, Carvajal-Carmona, L, Tomlinson, I P M, Kerr, D J, Houlston, R S, Piqué, J M, Carracedo, A, Castells, A, Andreu, M, Ruiz-Ponte, C, Castellví-Bel, S
Publicado 2011

A randomised, phase II study of intetumumab, an anti-α(v)-integrin mAb, alone and with dacarbazine in stage IV melanoma

por O'Day, S, Pavlick, A, Loquai, C, Lawson, D, Gutzmer, R, Richards, J, Schadendorf, D, Thompson, J A, Gonzalez, R, Trefzer, U, Mohr, P, Ottensmeier, C, Chao, D, Zhong, B, de Boer, C J, Uhlar, C, Marshall, D, Gore, M E, Lang, Z, Hait, W, Ho, P
Publicado 2011

Antitumour efficacy of MEK inhibitors in human lung cancer cells and their derivatives with acquired resistance to different tyrosine kinase inhibitors

por Morgillo, F, Cascone, T, D'Aiuto, E, Martinelli, E, Troiani, T, Saintigny, P, De Palma, R, Heymach, J V, Berrino, L, Tuccillo, C, Ciardiello, F
Publicado 2011

Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study

por Catto, J W F, Robinson, M C, Albertsen, P C, Goepel, J R, Abbod, M F, Linkens, D A, Davis, M, Rosario, D J, Warren, A Y, Varma, M, Griffiths, D F, Grigor, K M, Mayer, N J, Oxley, J D, Deshmukh, N S, Lane, J A, Metcalfe, C, Donovan, J L, Neal, D E, Hamdy, F C
Publicado 2011

Dual inhibition of epidermal growth factor and insulin-like 1 growth factor receptors reduce intestinal adenoma burden in the Apc(min/+) mouse

por Shaw, P H S, Maughan, T S, Clarke, A R
Publicado 2011

Effects of lapatinib monotherapy: results of a randomised phase II study in therapy-naive patients with locally advanced squamous cell carcinoma of the head and neck

por del Campo, J M, Hitt, R, Sebastian, P, Carracedo, C, Lokanatha, D, Bourhis, J, Temam, S, Cupissol, D, De Raucourt, D, Maroudias, N, Nutting, C M, Compton, N, Midwinter, D, Downie, L, Biswas-Baldwin, N, El-Hariry, I, Harrington, K J
Publicado 2011

Her2/neu extracellular domain shedding in uterine serous carcinoma: implications for immunotherapy with trastuzumab

por Todeschini, P, Cocco, E, Bellone, S, Varughese, J, Lin, K, Carrara, L, Guzzo, F, Buza, N, Hui, P, Silasi, D-A, Ratner, E, Azodi, M, Schwartz, P E, Rutherford, T J, Pecorelli, S, Santin, A D
Publicado 2011